AeroRx Therapeutics is a clinical‑stage biopharmaceutical company developing best‑in‑class nebulized combination therapies for moderate‑to‑severe chronic obstructive pulmonary disease (COPD). Based in La Jolla, California, it focuses on fixed‑dose LABA/LAMA and LABA/LAMA/ICS formulations delivered via nebulizer to serve patients who have difficulty using traditional inhalers.